Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Goran Orozovic"'
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89306 (2014)
Resistance to neuraminidase inhibitors (NAIs) is a growing problem in battle against influenza A virus. However, little is known about the resistance of viruses isolated from dabbling ducks, the natural reservoir of the influenza virus. To our knowle
Externí odkaz:
https://doaj.org/article/a312601ff55a4951b9c4f52b9e6cc558
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e16028 (2011)
The neuraminidase (NA) inhibitors oseltamivir and zanamivir are the first-line of defense against potentially fatal variants of influenza A pandemic strains. However, if resistant virus strains start to arise easily or at a high frequency, a new anti
Externí odkaz:
https://doaj.org/article/809190b63c334a078ce583ea82c49cc6
Autor:
Josef D Järhult, Shaman Muradrasoli, John Wahlgren, Hanna Söderström, Goran Orozovic, Gunnar Gunnarsson, Caroline Bröjer, Neus Latorre-Margalef, Jerker Fick, Roman Grabic, Johan Lennerstrand, Jonas Waldenström, Ake Lundkvist, Björn Olsen
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24742 (2011)
Oseltamivir (Tamiflu®) is the most widely used drug against influenza infections and is extensively stockpiled worldwide as part of pandemic preparedness plans. However, resistance is a growing problem and in 2008-2009, seasonal human influenza A/H1
Externí odkaz:
https://doaj.org/article/fb449c3e127349b8b9eb8188b851bc0e
Autor:
Natalie Stephenson, Natalia Ugulava, Goran Orozovic, Peter E. Brodelius, April Horsey, Vidadi Yusibov, Konstantin Musiychuk, Vadim Mett, Abdel-Moneim Shamloul, Hong Bi, Maria Brodelius, Christine E. Farrance, Stephen J. Streatfield, Shailaja Rabindran
Publikováno v:
Influenza and Other Respiratory Viruses. 1:19-25
Historically, most vaccines have been based on killed or live‐attenuated infectious agents. Although very successful at immunizing populations against disease, both approaches raise safety concerns and often have limited production capacity. This h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa5d0e48311875a170a3e08469c5e5c5
https://doi.org/10.1111/j.1750-2659.2006.00005.x
https://doi.org/10.1111/j.1750-2659.2006.00005.x
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89306 (2014)
PLoS ONE
PLoS ONE
Resistance to neuraminidase inhibitors (NAIs) is a growing problem in battle against influenza A virus. However, little is known about the resistance of viruses isolated from dabbling ducks, the natural reservoir of the influenza virus. To our knowle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f6a04a207cb4f62d264106c383b7cbb
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-221855
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-221855
Autor:
Jerker Fick, Gunnar Gunnarsson, Neus Latorre-Margalef, Caroline Bröjer, Roman Grabic, Johan Lennerstrand, Åke Lundkvist, Jonas Waldenström, Shaman Muradrasoli, Josef D. Järhult, Bjorn R. Olsen, Goran Orozovic, Hanna Söderström, John Wahlgren
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 9, p e24742 (2011)
PLoS ONE, Vol 6, Iss 9, p e24742 (2011)
Oseltamivir (Tamiflu (R)) is the most widely used drug against influenza infections and is extensively stockpiled worldwide as part of pandemic preparedness plans. However, resistance is a growing problem and in 2008-2009, seasonal human influenza A/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac08298631a612cb7e8ab02c8ef7102
https://pubmed.ncbi.nlm.nih.gov/31534254
https://pubmed.ncbi.nlm.nih.gov/31534254
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e16028 (2011)
PLoS ONE
PLoS ONE
The neuraminidase (NA) inhibitors oseltamivir and zanamivir are the first-line of defense against potentially fatal variants of influenza A pandemic strains. However, if resistant virus strains start to arise easily or at a high frequency, a new anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2922d206c9defc673e77fa040d48b4c6
https://doi.org/10.1371/journal.pone.0016028
https://doi.org/10.1371/journal.pone.0016028